Atlas Trials

Tolerance and Activity Evaluation of High Doses of Favipiravir Against Ebola Virus in the Semen

Clinical trial NCT02739477 · TERMINATED

Trial details

NCT number
NCT02739477
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Ebola Virus Survivor
Start date
2016-04-01
Primary completion
2016-08-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.